UBS O'Connor’s Quantum FinTech Acquisition Corporation Warrants, each warrant exercisable for one-half of one share of Common Stock at an exercise price of $11.50 QFTA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-101,052
Closed -$53K 1179
2021
Q4
$53K Sell
101,052
-98,941
-49% -$48K ﹤0.01% 905
2021
Q3
$53K Hold
199,993
﹤0.01% 887
2021
Q2
$69K Hold
199,993
﹤0.01% 853
2021
Q1
$61K Buy
+199,993
New +$75.7K ﹤0.01% 788

Other funds holding QFTA.WS

UBS O'Connor's QFTA.WS Position: Q1 2022 in Review

UBS O'Connor sold out of Quantum FinTech Acquisition Corporation Warrants, each warrant exercisable for one-half of one share of Common Stock at an exercise price of $11.50 (QFTA.WS) in Q1 2022, closing a stake of 101,052 shares — an estimated $53K sold.

UBS O'Connor first reported a position in QFTA.WS in Q1 2021 and held it in 4 quarters. The position peaked at $69K in Q2 2021. 30 funds tracked by Wall St. Rank hold QFTA.WS as of Q1 2022.

  • UBS O'Connor reported no remaining Quantum FinTech Acquisition Corporation Warrants, each warrant exercisable for one-half of one share of Common Stock at an exercise price of $11.50 position as of Q1 2022 after selling out during the quarter.
  • UBS O'Connor sold 101,052 Quantum FinTech Acquisition Corporation Warrants, each warrant exercisable for one-half of one share of Common Stock at an exercise price of $11.50 shares in Q1 2022, an estimated $53K.
  • UBS O'Connor first reported a position in Quantum FinTech Acquisition Corporation Warrants, each warrant exercisable for one-half of one share of Common Stock at an exercise price of $11.50 in Q1 2021 and held it in 4 quarters.
  • UBS O'Connor's Quantum FinTech Acquisition Corporation Warrants, each warrant exercisable for one-half of one share of Common Stock at an exercise price of $11.50 position peaked at $69K in Q2 2021.
  • 30 funds tracked by Wall St. Rank held Quantum FinTech Acquisition Corporation Warrants, each warrant exercisable for one-half of one share of Common Stock at an exercise price of $11.50 as of Q1 2022.

Based on UBS O'Connor's 13F filing for Q1 2022, filed 16 May 2022.